NCT07813247 Robotic Adrenalectomy With Versus Without Indocyanine Green Fluorescence Imaging
| NCT ID | NCT07813247 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Cleveland Clinic |
| Condition | Adrenalectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 55 participants |
| Start Date | 2026-07-31 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 55 participants in total. It began in 2026-07-31 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective randomized study comparing robotic adrenalectomy with versus without intraoperative indocyanine green imaging.
Eligibility Criteria
Inclusion Criteria: * adult patients scheduled for robotic adrenalectomy Exclusion Criteria: * patients scheduled for laparoscopic or open adrenalectomy or with an iodine allergy
Frequently Asked Questions
Who can join the NCT07813247 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Adrenalectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07813247 currently recruiting?
Yes, NCT07813247 is actively recruiting participants. Visit ClinicalTrials.gov or contact The Cleveland Clinic to inquire about joining.
Where is the NCT07813247 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT07813247 clinical trial?
NCT07813247 is sponsored by The Cleveland Clinic. The trial plans to enroll 55 participants.